(Q48946263)

17 February 2018

title

Is C-reactive protein level a marker of advanced motor and neuropsychiatric complications in Parkinson's disease? (English)

1 reference

17 February 2018

7

Joab Chapman

1 reference

17 February 2018

8

David Tanne

1 reference

17 February 2018

author name string

Sharon Hassin-Baer

1

1 reference

17 February 2018

Oren S Cohen

2

1 reference

17 February 2018

Eli Vakil

3

1 reference

17 February 2018

Noa Molshazki

4

1 reference

17 February 2018

Ben-Ami Sela

5

1 reference

17 February 2018

Zeev Nitsan

6

1 reference

17 February 2018

publication date

16 December 2010

1 reference

17 February 2018

Journal of Neural Transmission

published in

1 reference

17 February 2018

volume

118

1 reference

17 February 2018

issue

4

1 reference

17 February 2018

page(s)

539-543

1 reference

17 February 2018

https://scigraph.springernature.com/pub.10.1007/s00702-010-0535-z

exact match

0 references

cites work

Peripheral inflammatory biomarkers and risk of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0535-Z

Neuroinflammation of the nigrostriatal pathway during progressive 6-OHDA dopamine degeneration in rats monitored by immunohistochemistry and PET imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0535-Z

Glutathione peroxidase, glial cells and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0535-Z

The FAB: a Frontal Assessment Battery at bedside.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0535-Z

C-reactive protein-like immunoreactivity in the neurofibrillary tangles of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0535-Z

The in vitro neuronal toxicity of pentraxins associated with Alzheimer's disease brain lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0535-Z

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0535-Z

Mitochondrial dysfunction in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0535-Z

Neuroinflammation in Parkinson's disease: a target for neuroprotection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0535-Z

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0535-Z

Demonstration of CRP immunoreactivity in brains of Alzheimer's disease: immunohistochemical study using formic acid pretreatment of tissue sections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0535-Z

The etiopathogenesis of Parkinson disease and suggestions for future research. Part II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0535-Z

Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0535-Z

Clinical depression and inflammatory risk markers for coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0535-Z

Inflammatory process in Parkinson's disease: role for cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0535-Z

C-reactive protein accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0535-Z

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0535-Z

C-reactive protein and memory function suggest antagonistic pleiotropy in very old nondemented subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0535-Z

Is there an association between the level of high-sensitivity C-reactive protein and idiopathic Parkinson's disease? A comparison of Parkinson's disease patients, disease controls and healthy individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0535-Z

Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0535-Z

21 January 2018

1 reference

12 December 2020

Relation of C-reactive protein to stroke, cognitive disorders, and depression in the general population: systematic review and meta-analysis

1 reference

PubMed

12 December 2020

Parkinson Psychosis Rating Scale: a practical instrument for grading psychosis in Parkinson's disease

1 reference

PubMed

12 December 2020

Acute phase proteins in major depression

1 reference

PubMed

12 December 2020

10.1007/S00702-010-0535-Z

Identifiers

DOI

1 reference

17 February 2018

1 reference

17 February 2018